Newsbenzinga
One of Israel Englander's Biotech Picks Just Turned Into a $500M Merger Story
· Published
Article summary
Werewolf Therapeutics surged after announcing a $500 million merger with Ambros Therapeutics, putting focus on Israel Englander's holding.
An excerpt from the original article.
Comments —
Loading comments…